Welcome to LookChem.com Sign In|Join Free
  • or
4-Hexenoic acid, 6-[(2R)-7-amino-3,4,5,6-tetrahydro-2H-azepin-2-yl]-2-[[(phenylmethoxy) carbonyl]amino]-, phenylmethyl ester, (2S,4Z)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

396080-49-2

Post Buying Request

396080-49-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

396080-49-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 396080-49-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,9,6,0,8 and 0 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 396080-49:
(8*3)+(7*9)+(6*6)+(5*0)+(4*8)+(3*0)+(2*4)+(1*9)=172
172 % 10 = 2
So 396080-49-2 is a valid CAS Registry Number.

396080-49-2Upstream product

396080-49-2Downstream Products

396080-49-2Relevant academic research and scientific papers

COMBINATION THERAPY WITH INHIBITORS OF INDUCIBLE NITRIC OXIDE SYNTHASE AND ALKYLATING AGENTS

-

Page/Page column 125-126, (2010/02/11)

A combination therapy comprising administration of a carbamoylating chemotherapeutic agent in conjunction with administration of a selective iNOS inhibitor compound is disclosed. Optionally, resection and radiation therapy are provided with the therapeutic combination. A medicament comprising a carbamoylating chemotherapeutic agent and a selective iNOS inhibitor compound together with a pharmaceutically acceptable carrier is further disclosed. A kit comprising a carbamoylating chemotherapeutic agent and a selective iNOS inhibitor compound is further disclosed.

METHODS FOR TREATMENT AND PREVENTION OF GASTROINTESTINAL CONDITIONS

-

Page/Page column 128, (2010/02/06)

Therapeutic methods for the prevention ad treatment of conditions and diseases of the gastrointestinal tract involving an overproduction of nitric oxide by inducible nitric oxide synthase are described, the methods including administering to a subject in need thereof a therapeutically effective amount of a selective inhibitor of inducible nitric oxide synthase (iNOS). The methods also include the use of selective inhibitors of iNOs in combination with other therapeutic agents, including antimicrobial agents and antisecretory agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 396080-49-2